PT Kalbe Farma Tbk. Stock Forecast for 2023 - 2025 - 2030
Updated on 04/20/2024
PT Kalbe Farma Tbk. Stock Forecast and Price Target
According to six esteemed experts, the average price target for PT Kalbe Farma Tbk. to reach this year is Rp1700.00, with a potential upside of approximately 21.43%. This prediction is based on a high estimate of Rp2800.00 and a low estimate of Rp1550.00. You may be interested in rivals even if you aren't interested in PT Kalbe Farma Tbk. stock.
21.43% Upside
PT Kalbe Farma Tbk. Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, PT Kalbe Farma Tbk.'s Price has decreased by 100.00%, from Rp1580.78 to Rp0.00. For the next year, analysts are expecting Fair Value to reach Rp2229.26 – an increase of 100.00%. Over the next seven years, experts predict that Fair Value will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ROG Stock Forecast | Roche Holding | Hold |
16
|
CHF222.10 | Buy/Sell | CHF307.83 | 22.69% |
| SAN Stock Forecast | Sanofi | Outperform |
16
|
86.89€ | Buy/Sell | 102.80€ | 24.30% |
| GLENMARK Stock Forecast | Glenmark Pharmaceuticals | Outperform |
18
|
Rp1.03k | Buy/Sell | Rp767.80 | -11.88% |
| KAEF Stock Forecast | PT Kimia Farma Tbk | - |
14
|
Rp995.00 | Buy/Sell | Rp1.50k | -100.00% |
| DVLA Stock Forecast | PT Darya-Varia Laboratoria Tbk | - |
18
|
Rp1.65k | Buy/Sell | Rp0.00 | -100.00% |
PT Kalbe Farma Tbk. Revenue Forecast for 2023 - 2025 - 2030
In the last two years, PT Kalbe Farma Tbk.'s Revenue has grown by 25.18%, from Rp23.11T to Rp28.93T. For the next year, analysts are expecting Revenue to reach Rp34.10T – an increase of 17.85%. Over the next seven years, experts predict that Revenue will grow by 16.81%.
.jpg)
PT Kalbe Farma Tbk. Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, PT Kalbe Farma Tbk.'s Dividend per Share has grown from Rp28.00 to Rp38.00 – a 35.71% increase. According to 12 prominent analysts, PT Kalbe Farma Tbk.'s Dividend per Share will fall by 5.34% in the next year, reaching Rp35.97. By 2030, professionals believe that PT Kalbe Farma Tbk.'s Dividend per Share will decrease by 10.39%, reaching Rp34.05 – a concerning trend for the company.
PT Kalbe Farma Tbk. EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, PT Kalbe Farma Tbk.'s EBITDA has grown by 18.41%, rising from Rp4.14T to Rp4.90T. For next year, analysts predict EBITDA of Rp5.82T, which would mean an increase of 18.69%. Over the next seven years, experts predict that PT Kalbe Farma Tbk.'s EBITDA will grow at a rate of 16.19%.
PT Kalbe Farma Tbk. EBIT Forecast for 2023 - 2025 - 2030
In the last two years, PT Kalbe Farma Tbk.'s EBIT has grown, rising from Rp3.58T to Rp4.25T – a growth of 18.60%. In the next year, analysts believe that EBIT will reach Rp4.97T – an increase of 16.91%. For the next seven years, the forecast is for EBIT to grow by 17.48%.
PT Kalbe Farma Tbk. EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, PT Kalbe Farma Tbk.'s EPS has decreased by 100.00%, from Rp58.31 to Rp0.00. For the next year, analysts are expecting EPS to reach Rp82.23 – an increase of 100.00%. Over the next seven years, experts predict that EPS will grow by 100.00%.
.jpg)